News

News

3 Boomerang Capital Appoints Martin LeBlanc as Chairman of Strategic & Operational Advisory Board

January 23, 2025

3 Boomerang Capital ("3BC" or "3 Boomerang"), a healthcare-focused private equity firm committed to driving transformative growth for lower middle-market businesses, is proud to announce the appointment of Martin LeBlanc as chairman of its Strategic & Operational Advisory Board.

Learn more

Enjoin, LLC Appoints Healthcare Innovator Steve Hynes as Executive Chairman of its Board

December 5, 2024

Enjoin, LLC ("Enjoin" or the "Company") is pleased to announce that experienced healthcare leader Steve Hynes has joined its Board of Directors (the "Board") as executive chairman.

Learn more

3 Boomerang Capital Announces Growth Recapitalization of Enjoin, LLC

November 21, 2024

3 Boomerang Capital ("3BC" or "3 Boomerang"), a healthcare-focused, lower middle-market private equity firm, announces a majority growth investment in Enjoin, LLC ("Enjoin" or the "Company"), a leader in Clinical Documentation Integrity ("CDI") solutions for hospitals and health systems nationwide.

Learn more

3 Boomerang Capital Announces Strategic Growth Investment in Analytical Biological Services Inc.

June 24, 2024

3 Boomerang Capital has announced a strategic growth investment in Analytical Biological Services Inc. (ABS), marking the first platform investment of its newly closed Fund I.

Learn more

3 Boomerang Capital Closes Flagship Private Equity Fund Above Target

February 6, 2024

3 Boomerang Capital Raises Over $375 Million for Healthcare Private Equity Fund, Exceeding Target

Learn more